Previous studies have shown that IS induces cardiac hypertrophy by enhancing the generation of ROS and then regulates several hypertrophy-related signaling pathways, including the MAPK (47), AMPK (64), and NF-κB pathways (65). The gene discussed is NFKB1; the disease is cardiac hypertrophy.